Aviv Regev

Regev studied at the Adi Lautman Interdisciplinary Program for Outstanding Students of Tel Aviv University, where she completed her PhD under the supervision of Eva Jablonka,^[7] and Ehud Shapiro.^[8]

Career and research

In 2020, Regev became the Head and Executive Vice President of Genentech Research and Early Development, based in South San Francisco, and a member of the extended Corporate Executive Committee of Roche.^[9][10] Previously, she was a Core Institute Member (now on leave), Chair of the Faculty, Founding Director of the Klarman Cell Observatory and co-Director Cell Circuits Program at the Broad Institute of MIT and Harvard. She was also a professor in the Department of Biology at the Massachusetts Institute of Technology (now on leave), as well as an Investigator at the Howard Hughes Medical Institute. Regev's research^[11] includes work on gene expression^[12][13] (with Eran Segal and David Botstein), and the use of π-calculus to represent biochemical processes.^[14][15][16] Regev's team has been a leading pioneer of single-cell genomics experimental and computational methods.^[17] In 2014, she pitched the idea of the creation of Human Cell Atlas,^[18] a project to describe all cell types in the human body. Regev founded the Human Cell Atlas together with Sarah Teichmann along with collaborators all over the world.^{[citation needed]}

Single Cell Genomics

Regev's lab pioneered the development and application of many of the key experimental and computational advances for single cell and spatial genomics, especially single cell RNA-Seq (scRNA-seq).

Awards and honors

Regev is a fellow of the International Society of Computational Biology (ISCB) (2017),^[19] a Helmholtz Fellow (2020),^[20] and a fellow of the American Association for Cancer Research (AACR) (2021).^[21] She is a member of the US National Academy of Sciences (NAS, elected 2019)^[22] and of the US National Academy of Medicine (NAM, elected 2020).^[23]

• 25th L'Oréal-UNESCO For Women in Science Awards (Laureate for North America), 2023^[24]
• Elected to the American Academy of Arts and Sciences, 2022^[25]
• Anderson Lecture, University of Virginia, 2022^[26]
• Nakasone Award from the Human Frontiers Science Program (2022)^[27]
• Honorary doctorate, ETH Zurich (2021)^[28]
• Ernst Schering Prize (2021)^[29]
• James Prize in Science and Technology Integration, National Academy of Sciences (2021)^[30]
• Vanderbilt Prize (2021)^[31]
• She was awarded the 25th Keio Medical Science Prize in 2020.^[32][33]
• AACR-Irving Weinstein Foundation Distinguished Lecture (2021)^[34]
• Lurie Prize from the Foundation for the NIH (FNIH) (2020)^[35]
• Mendel Lecture, European Society of Human Genetics (2020)^[36]
• Jonathan Kraft Prize from Massachusetts General Hospital (2020)^[37]
• FASEB Excellence in Science Mid-Career Investigator Award (2019)^[38]
• She was elected a member of the National Academy of Sciences (NAS) in 2019.^[39]
• She also served on the Life Sciences jury for the Infosys Prize in 2018.
• Weatherall Lecture, University Oxford, UK (2018)^[40]
• Harvey Lecture, Harvey Society, New York (2018)^[41]
• McCormick Lecture, Stanford University (2018)^[42]
• Paul Marks Prize for Cancer Research (2017).^[43]
• ISCB Innovator Award in 2017.^[2][44]
• Earl and Thressa Stadtman Scholar Award from the American Society of Biochemistry and Molecular Biology (ASBMB) (2014)^[45]
• Burroughs Wellcome Fund Career Award.^[46]
• In 2008, she was also awarded the NIH Director's Pioneer Award.^[47][48]
• Regev was awarded the Overton Prize in 2008 for "outstanding accomplishment to a scientist in the early to mid stage of his or her career".^[1]

References